Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy-Reference-Cited by-同舟云学术

Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy

Published:2017-07 Issue:7 Volume:15 Page:1087-1094.e2
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Jacobson Ira M.,Washington Mary K.,Buti Maria,Thompson Alexander,Afdhal Nezam,Flisiak Robert,Akarca Ulus Salih,Tchernev Konstantin G.,Flaherty John F.,Aguilar Schall Raul^ORCID,Myers Robert P.,Subramanian G. Mani,McHutchison John G.,Younossi Zobair,Marcellin Patrick,Patel Keyur

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference38 articles.

1. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection;J Hepatol,2017

2. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update;Sarin;Hepatol Int,2016

3. No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B;Kitrinos;Hepatology,2014

4. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B;Chang;Hepatology,2010

5. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study;Marcellin;Lancet,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating metabolites are associated with persistent elevations of ALT in patients with chronic hepatitis B with complete viral suppression;Journal of Medical Virology;2024-06

2. Five-year Treatment with Tenofovir Alafenamide Achieves High Rates of Viral Suppression, Alanine Aminotransferase Normalization, and Favorable Bone and Renal Safety in Chinese Chronic Hepatitis B Patients;Journal of Clinical and Translational Hepatology;2024-04-15

3. Efficacy and its Predictors of Antiviral Therapy with Nucleos(T)Ide Analogs in Patients with Chronic Hepatitis B;The Russian Archives of Internal Medicine;2024-04-06

4. The co-existence of NAFLD and CHB is associated with suboptimal viral and biochemical response to CHB antiviral therapy: a systematic review and meta-analysis;Frontiers in Gastroenterology;2024-01-24

5. Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety;American Journal of Gastroenterology;2023-10-09